Skip to the card

2026-11-17 issue

Observed arrival · 2026-11-17

TargetVista keeps drug-target evidence and its gaps in the record

targetvista.bio Visit website
Editorial interest 79/100 Selection signal · not a rating of the site

A drug-discovery platform for reviewing target evidence, clinical history, tractability, and molecule-assessment methods.

Landing page captured for the 2026-11-17 issue.
For
Drug-discovery teams qualifying biological targets
Worth noticing
It separates measured negative results from missing or unqueried evidence instead of encoding both as zero.

Field notes

The homepage describes records assembled per target from primary sources including CIViC, CPIC, Open Targets, ChEMBL, ClinicalTrials.gov, and others, with source and read date attached. Its evidence states separate a finding, a measured negative, and an unestablished lookup; the latter is not rendered as zero. Candidate assessment is presented across AutoDock Vina, Boltz-2 co-folding, and developability filters, with stated pose and ranking constraints.

Observed signals

Read the marks

Editorial observations of this landing page, not a rating.

○OpenPublic substance visible
$PaidCommerce or pricing visible
✦PrettyNotable craft visible
●ProPolished or operationally mature
◎NicheUnusually specific use
ƒJavaScriptBrowser-side code central

One card from the complete issue

Real Weather in Mossy Hollow

300,778 arrived 1,000 judged 976 catalogued Enter the complete issue
targetvista.bio

Landing page observed 2026-11-17. The live site may have changed.